LIPOCINE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.7 USD | -0.21% |
|
+3.30% | +68.46% |
| May. 01 | Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 | CI |
| Apr. 12 | Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial | MT |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.
- Transcripts
